Cipla Limited partners with ImmunoACT to launch talicabtagene autoleucel CAR-T therapy for blood cancers in South Africa, ...

A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.

CNW/ - AstraZeneca Canada is pleased to announce that Tagrisso® (osimertinib) and Calquence® (acalabrutinib tablets) are now ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

JA Solar, a trusted global partner in green energy, is rapidly expanding the global deployment of its DeepBlue 5.0 modules across utility, C&I, and residential markets, as developers increasingly ...

GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Life Extension reports women live 5.4 years longer than men due to biological and behavioral factors, but men can narrow this gap with lifestyle changes.

A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...

Associate Professor Jaydee Cabral likens 3D bioprinting to baking a cake, but her research is anything but simple. From wound dressings and scar-preventing gels to bio-printed nipples and patient ...

Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...